Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.8K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.8K
Comparative Excretory Systems02:24

Comparative Excretory Systems

26.7K
Animals have evolved different strategies for excretion, the removal of waste from the body. Most waste must be dissolved in water to be excreted, so an animal’s excretory strategy directly affects its water balance.
26.7K
Comparing Experimental Results: Student's t-Test01:09

Comparing Experimental Results: Student's t-Test

6.1K
The t-test is a statistical method used to compare the sample mean with a population mean or compare two means from two data sets. The test statistic is calculated from the standard deviation, mean, and number of measurements in the data set at a selected confidence interval and then compared to a table of critical values at this confidence level. If the test statistic is smaller than the critical value, the null hypothesis is accepted. In this case, we state that the difference between the...
6.1K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

613
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
613
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

1.8K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.8K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

16.8K
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
16.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salbutamol Reversal of Methacholine Induced Bronchoconstriction: Vibrating Mesh Nebulizer versus Pressurized Metered Dose Inhaler.

Journal of asthma and allergy·2026
Same author

Methacholine Challenge: Physiology, Methodology, and Clinical Interpretation.

Clinics in chest medicine·2025
Same author

What's next for direct bronchoprovocation test methods?

Expert review of respiratory medicine·2025
Same author

To stop or not to stop an asthma biologic, that is the question.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same author

Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial.

The European respiratory journal·2024
Same author

Respiratory System Dynamics.

Seminars in respiratory and critical care medicine·2023

Related Experiment Video

Updated: Feb 10, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.9K

Methacholine challenge testing: comparative pharmacology.

Beth E Davis1, Christianne M Blais1, Donald W Cockcroft1

  • 1Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.

Journal of Asthma and Allergy
|May 23, 2018
PubMed
Summary
This summary is machine-generated.

Understanding medication washout periods is crucial for standardizing methacholine challenge tests. Bronchoprotective effects vary significantly among different drug classes, impacting test interpretation.

Keywords:
antihistaminebeta agonistbronchoprotectionglucocorticosteroidmethacholine challengemuscarinic antagonist

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
07:48

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

12.1K

Related Experiment Videos

Last Updated: Feb 10, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.9K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
07:48

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

12.1K

Area of Science:

  • Pulmonary Medicine
  • Pharmacology
  • Respiratory Physiology

Background:

  • The methacholine inhalation challenge is a key diagnostic tool for asthma.
  • Standardizing this test requires understanding how various medications influence airway responsiveness.
  • Pharmacologic agents can inhibit or alter the methacholine response, necessitating defined washout periods.

Purpose of the Study:

  • To review and summarize existing data on the duration of pharmacologic inhibition of the methacholine response.
  • To inform standardization protocols for the methacholine challenge test by clarifying medication washout requirements.
  • To compare the bronchoprotective effects and durations of different drug classes.

Main Methods:

  • Systematic review of literature on pharmacologic agents and their effect on methacholine challenge tests.
  • Analysis of data on specific (anti-muscarinic) agents, functional antagonists (beta-2 agonists), inhaled corticosteroids (ICS), leukotriene receptor antagonists, theophylline, and H1 blockers.
  • Evaluation of the duration of bronchoprotection versus bronchodilator efficacy for each drug class.

Main Results:

  • Specific anti-muscarinic agents provide significant bronchoprotection for up to 7 days, exceeding bronchodilator duration.
  • Beta-2 agonists offer shorter-lived, but marked, bronchoprotection, similar to their bronchodilator effects, with rapid tolerance development.
  • Controller medications like ICS and leukotriene receptor antagonists have minimal acute effects, though regular ICS use shows modest, variable protection.

Conclusions:

  • Washout periods for methacholine challenge testing must account for the prolonged bronchoprotective effects of certain medications, particularly long-acting anti-muscarinics.
  • The duration of pharmacologic inhibition varies greatly, with anti-muscarinics lasting longer than beta-2 agonists.
  • Accurate interpretation of methacholine challenge tests necessitates adherence to appropriate washout periods based on medication class and duration of use.